Your S&P 500 fund can do more for you — here’s how
What you add to the S&P 500 can spice up your results, for higher returns and possibly lower risks
Three reasons Generation X thinks reality bites when it comes to retirement
Gen X will start turning 60 next year, and they’re less optimistic than baby boomers about their retirement prospects. Here’s why.
Morgan Stanley reportedly planning four-part bond deal a day after blowout earnings
Morgan Stanley is planning to tap the investment-grade bond market later Wednesday with a four-part deal divided between four-year, six-year and 11-year notes, Bloomberg reported.
Comcast launches prepaid and month-to-month internet and phone plans
Comcast announced Wednesday it is launching NOW, a new prepaid and month-to-month streaming and phone plan aimed at lower-income customers.
Most doses of Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says
The insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk work to increase production capacity.
American pandemic savings have depleted faster than other countries. Is that good or bad?
Mohammed El-Erian took to social media on Wednesday to post a chart, drawing on International Monetary Fund research, showing that the U.S. has depleted pandemic...
Sage Therapeutics’ stock plunges as Parkinson’s drug trial disappoints
Sage Therapeutics shares dropped early Wednesday after the company said its experimental treatment for mild cognitive impairment in patients with Parkinson’s disease fell flat in...
Tech layoffs still in spotlight after Apple and Take-Two cuts. But how does 2024 compare to 2023?
The tech sector layoffs that characterized 2023 have continued into 2024 with a number of big-name companies announcing cuts.
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year.